12-13567109-G-T
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000834.5(GRIN2B):c.2514C>A(p.Cys838*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. C838C) has been classified as Benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000834.5 stop_gained
Scores
Clinical Significance
Conservation
Publications
- complex neurodevelopmental disorderInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen, Ambry Genetics
- developmental and epileptic encephalopathy, 27Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- intellectual disability, autosomal dominant 6Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- autosomal dominant non-syndromic intellectual disabilityInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- infantile spasmsInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GRIN2B | NM_000834.5 | c.2514C>A | p.Cys838* | stop_gained | Exon 13 of 14 | ENST00000609686.4 | NP_000825.2 | |
| GRIN2B | NM_001413992.1 | c.2514C>A | p.Cys838* | stop_gained | Exon 14 of 15 | NP_001400921.1 | ||
| GRIN2B | XM_005253351.3 | c.300C>A | p.Cys100* | stop_gained | Exon 3 of 4 | XP_005253408.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GRIN2B | ENST00000609686.4 | c.2514C>A | p.Cys838* | stop_gained | Exon 13 of 14 | 1 | NM_000834.5 | ENSP00000477455.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Intellectual disability, autosomal dominant 6;C4015316:Developmental and epileptic encephalopathy, 27 Pathogenic:1
This sequence change creates a premature translational stop signal (p.Cys838*) in the GRIN2B gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GRIN2B are known to be pathogenic (PMID: 28377535). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with GRIN2B-related conditions. For these reasons, this variant has been classified as Pathogenic.
not provided Pathogenic:1
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge
Intellectual disability, autosomal dominant 6 Pathogenic:1
This variant was detected in a female with severe intellectual disability. The variant was confirmed to be of a de novo origin. Rare truncating variants affecting the GRIN2B gene are documented as a molecular cause of autosomal dominant "intellectual developmental disorder 6 with or without seizures" MRD6, OMIM:613970) (PMID:36704660;27818011;31807283). To conclude, the variant is classified as pathogenic (ACMG PVS1, PM2, PS2).
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at